1. KD. Tripathi. Haematinics and Erythropoietin. Essentials of medical pharmacology. Seventh edition. 2013. Page – 608-609.
2. Kenneth Kaushansky and Thomas J. Kipps. Hematopoietic agents: growth factors, minerals and vitamins. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1088-1092.
3. Kenichi Izumi, Takehiro Fujise, Kanako Inoue, Hitoe Mori, Kouta Yamazaki, Yui Hongou, Satoko Takagi, Hiroko Yamanouchi, Kenji Ashida, Keizo Anzai. [Mecobalamin improved pernicious anemia in an elderly individual with Hashimoto's disease and diabetes mellitus]. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. 2013. [Accessed 26th November 2020] https://pubmed.ncbi.nlm.nih.gov/24047671/
4. Amrita Sil, Hrishikesh Kumar, Rahul Deb Mondal, Sidharth Sankar Anand, Anirban Ghosal, Ashis Datta, Sandesh V Sawant, Vaibhavi Kapatkar, Ganesh Kadhe and Sameer Rao. A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy. NCBI; PMC US National Library of Medicine, National Institute of Health. July 2018. [Accessed 25th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037815/
5. National Pharmaceutical Regulatory Agency. [Revised on March 2013] [Accessed 26th November 2020] https://www.npra.gov.my/images/reg-and-noti/PI/non-poison/Mecobalamin-Template-oral-Website.pdf
6. Methylcobalamine 1500mcg oral tablets. Central Drugs Standard Control Organisation. [Revised on July 2005] [Accessed 26th November 2020] https://cdscoonline.gov.in/CDSCO/Drugs